TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06461533 updates: 1. completion date: 2029-10-31 → 2028-05-31 2. primary completion date: 2029-10-31 → 2028-05-31
Clinical trial NCT06461533 updates: 1. completion date: 2029-10-31 → 2028-05-31 2. primary completion date: 2029-10-31 → 2028-05-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical